SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002653
Filing Date
2015-11-13
Accepted
2015-11-13 06:08:54
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirn-20150930x10q.htm 10-Q 1603390
2 EX-31.1 mirn-20150930ex311e1e8d3.htm EX-31.1 18212
3 EX-31.2 mirn-20150930ex31285a1be.htm EX-31.2 17945
4 EX-32.1 mirn-20150930ex32163bd2a.htm EX-32.1 11726
  Complete submission text file 0001558370-15-002653.txt   4472011

Data Files

Seq Description Document Type Size
5 EX-101.INS mirn-20150930.xml EX-101.INS 730993
6 EX-101.SCH mirn-20150930.xsd EX-101.SCH 33001
7 EX-101.CAL mirn-20150930_cal.xml EX-101.CAL 28475
8 EX-101.DEF mirn-20150930_def.xml EX-101.DEF 115601
9 EX-101.LAB mirn-20150930_lab.xml EX-101.LAB 277136
10 EX-101.PRE mirn-20150930_pre.xml EX-101.PRE 211256
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 151226791
SIC: 2834 Pharmaceutical Preparations